BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant drop in short interest in the month of December. As of December 15th, there was short interest totaling 1,083 shares, a drop of 63.8% from the November 30th total of 2,988 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 9,969 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 9,969 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold.

BioNxt Solutions Price Performance

Shares of OTCMKTS BNXTF opened at $0.45 on Friday. The company has a market cap of $52.44 million, a price-to-earnings ratio of -11.33 and a beta of 0.82. The stock’s 50-day moving average is $0.52 and its two-hundred day moving average is $0.54. BioNxt Solutions has a 1-year low of $0.21 and a 1-year high of $0.80.

BioNxt Solutions (OTCMKTS:BNXTF) last announced its quarterly earnings data on Friday, November 28th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.01 million during the quarter.

About BioNxt Solutions

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.